Related Experiment Video
Updated: Aug 16, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Hypertension and coronary artery disease: an unsolved problem
1University Department of Medicine & Pharmacology, Royal Hallamshire Hospital, Sheffield, England.
Insights
Drug treatment for hypertension significantly lowers stroke risk and prevents heart and kidney failure. However, its impact on coronary artery disease prevention is less than expected, suggesting alternative strategies are needed.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Public Health
Background:
- Hypertension is a major risk factor for cardiovascular events.
- Antihypertensive drug therapy is widely used to manage high blood pressure.
- Previous studies indicated significant benefits of blood pressure reduction.
Purpose of the Study:
- To evaluate the effectiveness of antihypertensive drug treatment on coronary artery disease.
- To compare the observed reduction in coronary events with anticipated reductions from epidemiological data.
- To assess the potential impact of drug side effects on coronary event rates.
Main Methods:
- Analysis of major clinical trials on drug treatment for hypertension.
- Comparison of actual coronary event reduction with expected values.
- Estimation of potential shortfall in coronary prevention attributable to drug effects.
Main Results:
- Antihypertensive drugs reduced stroke incidence by 40% and prevented cardiac/renal failure.
- Coronary events were reduced by approximately 14%, lower than the 20-25% anticipated.
- The shortfall in coronary prevention potentially attributable to drug effects was estimated at 6-11%.
Conclusions:
- Current antihypertensive drugs show less efficacy in preventing coronary events than expected.
- There is no clear preference for any drug class for coronary prevention.
- Further research into strategies beyond blood pressure reduction is necessary for coronary disease prevention in hypertensive patients.
Abstract:
Drug treatment of hypertension reduced the incidence of stroke by 40% and prevented cardiac and renal failure, but had less effect on coronary artery disease in the major trials. Coronary events were reduced by about 14% (confidence limits of 4-22%), which compares to the reduction of 20-25% anticipated from epidemiological studies. Any shortfall in coronary prevention that could be attributable to adverse effects of antihypertensive drugs would therefore amount to only 6-11% of all coronary events, and could easily arise by chance. At present, there are no grounds for preferring one class of drug over another from the point of view of coronary prevention, or for altering the "target" diastolic pressure during treatment. Strategies other than blood pressure reduction aimed at preventing coronary disease in hypertensive subjects need to be explored. They should, however, be examined in large controlled outcome trials, and should not be introduced to ordinary practice on the basis of the inadequate evidence currently available.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
07:53Standardized Rat Coronary Ring Preparation and Real-Time Recording of Dynamic Tension Changes Along Vessel Diameter
Published on: June 16, 2022
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies